FDA Approves Secukinumab for Children with Enthesitis-Related Arthritis & PsA
Considerations for Prescribing Avacopan for ANCA-Associated Vasculitis
FDA Approves Cyltezo, an Interchangeable Biosimilar to Humira
FDA Grants Octapharma 7-Year Market Exclusivity for Octagam 10%
FDA Approves IVIG to Treat Adults with Dermatomyositis
AbbVie, Lilly Face New Delays in FDA Approval for Expanded Use of Janus Kinase Inhibitors
FDA Approves Tocilizumab to Treat Systemic Sclerosis-Associated ILD
FDA Approves Belimumab & Voclosporin for Lupus Nephritis